From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: the fraudster's best friend in journalism, Ben Harrington, does his master's bidding again

By Tom Winnifrith | Friday 22 June 2018


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


In today's podcast I cover in detail Telit (TCM) and also look at MySquar (MYSQ) partially in light of today's stunning news HERE. I look at Audioboom (BOOM), Frontera (FRR), Woodford Patient Capital Trust (WPCT), Prime People (PRP) and 88 Energy (88E). Tomorrow I will be bored to death by Lucian Miers, he will drone on about West Ham for 6 hours as we complete a 19 mile training walk from Bristol along the Avon to a few miles past Bath. I am building up to my 32 mile walk for Woodlarks with Brokerman Dan on 28 July. Think of my suffering tomorrow and please donate a small sum HERE.

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:29:03